Cancer Research
New Genetic Discovery Enhances Cancer Immunotherapy Potential
A groundbreaking genetic discovery could significantly improve the effectiveness of cancer immunotherapy, offering new hope for patients with certain types of cancer.
Lantern Pharma's Starlight Therapeutics Receives FDA Clearance for GBM Combination Trial
Starlight Therapeutics, a subsidiary of Lantern Pharma, has been cleared by the FDA to begin a Phase Ib/2a clinical trial for a novel combination therapy targeting glioblastoma multiforme, a move that could significantly impact treatment options for this aggressive brain cancer.
Intensity Therapeutics Secures $6.6 Million to Advance Cancer Treatment Research
Intensity Therapeutics raises $6.6 million through an At-the-Market offering to fund clinical trials for its innovative cancer therapy, INT230-6, marking a significant step forward in the fight against cancer.
Genetic Breakthrough Could Personalize Brain Tumor Treatment
Researchers at the University of Kentucky have discovered a genetic biomarker that could help predict which glioblastoma patients may benefit from the drug bevacizumab, offering a new avenue for personalized cancer treatment.
Nan Thai Buckhead and Chef Joey Ward Unite for Charity Dinner Benefiting CURE Childhood Cancer
Nan Thai Buckhead and MICHELIN-recommended chef Joey Ward collaborate for a charity dinner on August 26, 2025, to support CURE Childhood Cancer, highlighting the importance of community and culinary excellence in philanthropy.
Study Reveals Autoantibodies' Role in Enhancing Cancer Immunotherapy Efficacy
A recent study highlights the potential of autoantibodies in predicting the effectiveness of cancer immunotherapy, offering a new avenue for personalized treatment strategies.
Creative Biolabs to Showcase Tumoroid-on-a-Chip Technology in Upcoming Webinar
Creative Biolabs is set to host a webinar on tumoroid-on-a-chip technology, highlighting its potential to revolutionize cancer research and drug development by offering more physiologically relevant conditions for preclinical testing.
Experimental mRNA Vaccine Shows Promise in Enhancing Cancer Immunotherapy
Researchers have discovered that an experimental mRNA vaccine could significantly improve the effectiveness of immunotherapy in fighting tumors, marking a potential advancement towards universal cancer vaccines.
Community Foundation of Broward Awards $900,000 in Grants for Cancer Research
The Community Foundation of Broward has awarded two grants totaling $900,000 to support innovative cancer research and treatment accessibility in Broward County, focusing on lung cancer biomarkers and melanoma immunotherapies.
Curebound Aims to Accelerate Cancer Cures Amid NIH Funding Cuts
Curebound, under the leadership of COO Karen Hooper, is intensifying efforts to fund innovative cancer research, especially critical in light of recent NIH funding cuts, to accelerate cures within our lifetime.
Calidi Biotherapeutics Inc. Secures $4.6 Million Through Warrant Exercise Agreement
Calidi Biotherapeutics Inc. has raised $4.6 million by exercising outstanding warrants, funding its innovative cancer treatment research and development efforts.
Calidi Biotherapeutics' Genetic Medicine Platform Highlighted for Potential Cancer Breakthrough
Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been featured in an editorial for its precision genetic medicine platform, which could revolutionize cancer treatment by targeting tumors with engineered viruses.
UC Davis Study Uncovers Genetic Mutation Affecting Immunotherapy Response in Solid Tumors
A study by UC Davis scientists reveals a genetic mutation that may explain why solid tumors are unresponsive to immunotherapy, potentially leading to more effective cancer treatments.
Tonix Pharmaceuticals' TNX-1700 Shows Promise in Enhancing Immunotherapy for Gastric Cancer
Tonix Pharmaceuticals' preclinical data reveals TNX-1700's potential to improve immunotherapy outcomes in gastric cancer by targeting immunosuppressive neutrophils.
Fermented Wheat Germ Could Enhance Immunotherapy Outcomes for Cancer Patients
A clinical trial at UC Davis is exploring the potential of fermented wheat germ to improve immunotherapy results for cancer patients, offering hope for better survival rates and quality of life.
Research Reveals Why Most Smokers Avoid Lung Cancer Despite Tobacco Use
A new study explains the biological mechanisms that protect most smokers from developing lung cancer, offering insights into prevention and treatment strategies.
New Study Highlights Challenges and Systemic Barriers for Liver Cancer Patients
A recent study reveals the significant hurdles faced by hepatocellular carcinoma patients, including delayed diagnoses and social stigma, calling for systemic healthcare reforms.
Rising Breast Cancer Cases Among Younger Women Highlight Need for Advanced Treatments
Recent announcements by young celebrities about their breast cancer diagnoses underscore a worrying trend of increasing prevalence among women under 50, prompting calls for more effective treatments and research into the causes.
New Therapeutic Target Offers Hope in Preventing Cancer from Chronic Gut Inflammation
Research highlights a promising therapeutic target that could prevent cancer in patients suffering from chronic inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, offering new hope for young patients particularly affected by these conditions.
Study Highlights Delayed Cancer Diagnosis in Younger Populations
Research from the University of Nottingham shows younger individuals with certain cancers face longer diagnosis times, underscoring the need for improved detection and treatment strategies.
Korean Researchers Develop AI Model to Enhance Cancer Immunotherapy Precision
A South Korean research team has created an innovative AI model capable of predicting patient responses to immunotherapy for colorectal and gastric cancers, potentially revolutionizing personalized cancer treatment strategies.
University of Houston Receives $3M Grant to Advance Cancer Immunotherapy Research
The Texas Cancer Prevention & Research Institute awarded the University of Houston $3 million to establish a biomarker core, potentially transforming cancer research and patient outcomes through advanced immunotherapy techniques.
Creative Biolabs Unveils Advanced Bispecific Antibody Platform at Industry Conference
Creative Biolabs demonstrates cutting-edge bispecific antibody technology with potential to revolutionize cancer immunotherapy, showcasing customized development capabilities and innovative research approaches.
CNS Pharmaceuticals Raises $5 Million in Public Offering to Advance Brain Cancer Research
CNS Pharmaceuticals secures $5 million in funding through a public offering, aimed at supporting the development of innovative brain cancer treatments, with a focus on its lead drug candidate Berubicin.
Researchers Highlight Promising Anticancer Natural Product Synthesis Challenges
A systematic review of heterocyclic natural products reveals significant potential for anticancer drug development while identifying key challenges in synthesizing these compounds efficiently and sustainably.
Kairos Pharma to Showcase Oncology Research at D. Boral Capital Global Conference
Kairos Pharma will participate in the D. Boral Capital Inaugural Global Conference, offering investors insights into its innovative cancer therapeutic research, focusing on overcoming drug resistance with its lead candidate ENV105.
Study Reveals Pregnancy-Related Genes Contribute to Worse Lung Cancer Outcomes in Women
A new study from Memorial Sloan Kettering Cancer Center has uncovered how certain genes associated with pregnancy may negatively impact lung cancer survival rates in women, providing insights into potential future immune therapy developments.
Pacylex Pharmaceutical Explores N-myristoyltransferase Inhibitors as Potential ADC Cancer Therapies
Pacylex Pharmaceuticals is presenting innovative research on N-myristoyltransferase (NMT) inhibitors as potential payloads for antibody drug conjugates (ADCs), highlighting promising early clinical results in cancer treatment across multiple tumor types.
Kairos Pharma to Present Promising Cancer Treatment Data at 2025 ASCO Meeting
Kairos Pharma will showcase new research on KROS 101, a small molecule GITR ligand agonist, potentially offering insights into innovative cancer treatment approaches at the prestigious ASCO Annual Meeting.
Ohio State Researchers Uncover Potential Breakthrough in Glioblastoma Treatment
Scientists have identified a key enzyme, PGM3, that could be crucial in developing more effective treatments for glioblastoma, one of the deadliest forms of brain cancer by targeting a critical growth pathway.